Medical device manufacturer Boston Scientific is to invest €26m in research and development at its facility in Clonmel, Co Tipperary, the company has announced.
The Government, through IDA Ireland, is supporting the investment.
The new funds will enable Boston Scientific to expand its R&D and technical capabilities regarding the design of its next-generation cardiac rhythm management devices manufactured at the Clonmel facility.
Enterprise Minister Richard Bruton said such investments not only create high-value jobs but also provide spin-off benefits for Irish businesses, researchers and the Irish economy.
Brad Sorenson, vice-president of operations for Boston Scientific, said the funding will benefit the company’s cariology, rhythm and vascular group by enhancing its ability to provide R&D, design and manufacturing support for its medical device technologies.
“I am confident that, with the talent and expertise of our Clonmel staff, we can continue to successfully commercialise new life-saving innovations for our customers and their patients worldwide,” Sorenson said.
In Ireland, Boston Scientific also has campuses in Clonmel, Galway and Cork.
